muricholic acid has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
Studies (muricholic acid) | Trials (muricholic acid) | Recent Studies (post-2010) (muricholic acid) | Studies (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Trials (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Recent Studies (post-2010) (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) |
---|---|---|---|---|---|
119 | 1 | 36 | 3,412 | 41 | 631 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coleman, R; Elias, E; Milkiewicz, P; Roma, MG | 1 |
1 other study(ies) available for muricholic acid and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Article | Year |
---|---|
Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analysis of Variance; Animals; Bucladesine; Calcium; Carbazoles; Chelating Agents; Cholagogues and Choleretics; Cholestasis; Cholic Acids; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Indoles; Liver; Male; Protein Kinase C; Pyrroles; Rats; Signal Transduction; Staurosporine; Taurochenodeoxycholic Acid; Taurolithocholic Acid | 2002 |